中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
16期
69-70,73
,共3页
慢性荨麻疹%递减疗法%依巴斯汀%赛庚啶%多塞平
慢性蕁痳疹%遞減療法%依巴斯汀%賽庚啶%多塞平
만성담마진%체감요법%의파사정%새경정%다새평
Chronic urticaria%Decrease progressively treatment%Ebastine%Cyproheptadine%Doxepin
目的：评价依巴斯汀联合赛庚啶、多塞平递减疗法治疗慢性荨麻疹的疗效。方法：将209例患者随机分为两组，治疗组106例采用依巴斯汀联合赛庚啶、多塞平递减疗法；对照组103例采用依巴斯汀连续服用方法。结果：治疗组和对照组有效率及停药4周后复发率分别为76.1%、10.4%和43.5%、22.8%。两组有效率及复发率比较差异具有统计学意义(P＜0.05)。结论：依巴斯汀联合赛庚啶、多塞平递减疗法治疗慢性荨麻疹疗效佳、安全性高、复发率低，不良反应与单用依巴斯汀相似。
目的：評價依巴斯汀聯閤賽庚啶、多塞平遞減療法治療慢性蕁痳疹的療效。方法：將209例患者隨機分為兩組，治療組106例採用依巴斯汀聯閤賽庚啶、多塞平遞減療法；對照組103例採用依巴斯汀連續服用方法。結果：治療組和對照組有效率及停藥4週後複髮率分彆為76.1%、10.4%和43.5%、22.8%。兩組有效率及複髮率比較差異具有統計學意義(P＜0.05)。結論：依巴斯汀聯閤賽庚啶、多塞平遞減療法治療慢性蕁痳疹療效佳、安全性高、複髮率低，不良反應與單用依巴斯汀相似。
목적：평개의파사정연합새경정、다새평체감요법치료만성담마진적료효。방법：장209례환자수궤분위량조，치료조106례채용의파사정연합새경정、다새평체감요법；대조조103례채용의파사정련속복용방법。결과：치료조화대조조유효솔급정약4주후복발솔분별위76.1%、10.4%화43.5%、22.8%。량조유효솔급복발솔비교차이구유통계학의의(P＜0.05)。결론：의파사정연합새경정、다새평체감요법치료만성담마진료효가、안전성고、복발솔저，불량반응여단용의파사정상사。
Objective:To evaluate the curative effect of ebastine combined with cyproheptadine,doxepin decrease progressively in the treatment of chronic urticaria.Methods:209 patients were randomly divided into two groups.106 cases in the treatment group were given ebastine combined with cyproheptadine,doxepin decrease progressively treatment.103 cases in the control group were given ebastine continuous taking method.Results:The effective rates and recurrence rates after drug withdrawal 4 weeks of the treatment group and the control group were 76.1%,10.4% and 43.5%,22.8%.The effective rates and recurrence rates of two groups were compared with significant difference(P<0.05).Conclusion:Ebastine combined with cyproheptadine,doxepin decrease progressively in the treatment of chronic urticaria has good curative effect,high safety,low recurrence rate.Its adverse reaction is similar with single ebastine.
